Sangamo Therapeutics Announces Data From STAC-BBB Demonstrating 'robust penetration of the blood-brain barrier (BBB) and strong transgene expression throughout the central nervous system (CNS) of NHPs'
Author: Benzinga Newsdesk | March 13, 2024 08:06am